Abiopharma

🔍 Duvenhage Werner (Executive)

Company: ENERGY FUELS INC (UUUU)

Report Date: 2026-08-04

Detailed Transactions and Holdings:

• Acquired 10,796 shares of Common Shares (Direct)
  Date: 2026-08-04 | Code: A | equity_swap_involved: false | shares_owned_after: 10,796.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 11,830 shares of Performance-Based Stock Options at $13.37 per share (Derivative)
  Date: 2026-08-04 | Code: A | Expires: 2031-08-03 | equity_swap_involved: false | shares_owned_after: 11,830.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: The amount reported in Table I, Section 4 represents unvested restricted stock units ("RSUs") issued at a price of $12.15/common share, which were granted to Reporting Person by the Issuer, effective as of August 4, 2026, and vesting as follows: 50% on 01/27/2027; 25% on 01/27/2028; and 25% on 01/27/2029.
• F2: The amount reported in Table II, Section 5 represents 11,830 unvested Performance-Based Stock Options granted to Reporting Person by the Issuer with a strike price at a 10% premium from the grant price of $12.15, effective as of August 4, 2026 and vesting as follows 50% one year from the effective date of grant; and 50% two years from the effective date of grant. The grant has a term of five years.
• REMARKS: This Form 4 is being filed late due to an inability to secure Reporting Person's SEC filing codes within two business days of the grant date, which was one day after his effective date of employment.